Literature DB >> 28515293

Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Danyang Gong1, Xinghong Dai1, Yuchen Xiao2, Yushen Du1, Travis J Chapa1, Jeffrey R Johnson3, Xinmin Li4, Nevan J Krogan3, Hongyu Deng5, Ting-Ting Wu1, Ren Sun6.   

Abstract

Virus-like vesicles (VLVs) are membrane-enclosed vesicles that resemble native enveloped viruses in organization but lack the viral capsid and genome. During the productive infection of tumor-associated gammaherpesviruses, both virions and VLVs are produced and are released into the extracellular space. However, studies of gammaherpesvirus-associated VLVs have been largely restricted by the technical difficulty of separating VLVs from mature virions. Here we report a strategy of selectively isolating VLVs by using a Kaposi's sarcoma-associated herpesvirus (KSHV) mutant that is defective in small capsid protein and is unable to produce mature virions. Using mass spectrometry analysis, we found that VLVs contained viral glycoproteins required for cellular entry, as well as tegument proteins involved in regulating lytic replication, but lacked capsid proteins. Functional analysis showed that VLVs induced the expression of the viral lytic activator RTA, initiating KSHV lytic gene expression. Furthermore, employing RNA sequencing, we performed a genomewide analysis of cellular responses triggered by VLVs and found that PRDM1, a master regulator in cell differentiation, was significantly upregulated. In the context of KSHV replication, we demonstrated that VLV-induced upregulation of PRDM1 was necessary and sufficient to reactivate KSHV by activating its RTA promoter. In sum, our study systematically examined the composition of VLVs and demonstrated their biological roles in manipulating host cell responses and facilitating KSHV lytic replication.IMPORTANCE Cells lytically infected with tumor-associated herpesviruses produce a high proportion of virus-like vesicles (VLVs). The composition and function of VLVs have not been well defined, largely due to the inability to efficiently isolate VLVs that are free of virions. Using a cell system capable of establishing latent KSHV infection and robust reactivation, we successfully isolated VLVs from a KSHV mutant defective in the small capsid protein. We quantitatively analyzed proteins and microRNAs in VLVs and characterized the roles of VLVs in manipulating host cells and facilitating viral infection. More importantly, we demonstrated that by upregulating PRDM1 expression, VLVs triggered differentiation signaling in targeted cells and facilitated viral lytic infection via activation of the RTA promoter. Our study not only demonstrates a new strategy for isolating VLVs but also shows the important roles of KSHV-associated VLVs in intercellular communication and the viral life cycle.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  EBV; KSHV; PRDM1; RTA; envelope protein; extracellular vesicle; herpesvirus; microRNA; tegument protein; virus-like vesicle

Mesh:

Substances:

Year:  2017        PMID: 28515293      PMCID: PMC5651724          DOI: 10.1128/JVI.00362-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Authors:  D F Martin; B D Kuppermann; R A Wolitz; A G Palestine; H Li; C A Robinson
Journal:  N Engl J Med       Date:  1999-04-08       Impact factor: 91.245

2.  Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara.

Authors:  Danièle Spehner; Robert Drillien
Journal:  Virus Res       Date:  2008-08-13       Impact factor: 3.303

Review 3.  AIDS-related malignancies.

Authors:  Chris Boshoff; Robin Weiss
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

4.  ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation.

Authors:  Tomoharu Yasuda; Kohei Kometani; Noriko Takahashi; Yuuki Imai; Yuichi Aiba; Tomohiro Kurosaki
Journal:  Sci Signal       Date:  2011-04-19       Impact factor: 8.192

5.  Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants.

Authors:  Réjean Cantin; Juliette Diou; Dave Bélanger; Alexandre M Tremblay; Caroline Gilbert
Journal:  J Immunol Methods       Date:  2008-07-31       Impact factor: 2.303

6.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

7.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Modulation of B-cell exosome proteins by gamma herpesvirus infection.

Authors:  David G Meckes; Harsha P Gunawardena; Robert M Dekroon; Phillip R Heaton; Rachel H Edwards; Sezgin Ozgur; Jack D Griffith; Blossom Damania; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

9.  B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Fuqu Yu; Jiaying Feng; Josephine N Harada; Sumit K Chanda; Shannon C Kenney; Ren Sun
Journal:  FEBS Lett       Date:  2007-06-29       Impact factor: 4.124

Review 10.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

View more
  9 in total

1.  Structures of capsid and capsid-associated tegument complex inside the Epstein-Barr virus.

Authors:  Wei Liu; Yanxiang Cui; Caiyan Wang; Zihang Li; Danyang Gong; Xinghong Dai; Guo-Qiang Bi; Ren Sun; Z Hong Zhou
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

2.  A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells.

Authors:  Yiping Wang; Nathan Ungerleider; Brett A Hoffman; Mehmet Kara; Paul J Farrell; Erik K Flemington; Nara Lee; Scott A Tibbetts
Journal:  mBio       Date:  2022-06-01       Impact factor: 7.786

3.  DNA-Packing Portal and Capsid-Associated Tegument Complexes in the Tumor Herpesvirus KSHV.

Authors:  Danyang Gong; Xinghong Dai; Jonathan Jih; Yun-Tao Liu; Guo-Qiang Bi; Ren Sun; Z Hong Zhou
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

Review 4.  Defective viral genomes are key drivers of the virus-host interaction.

Authors:  Marco Vignuzzi; Carolina B López
Journal:  Nat Microbiol       Date:  2019-06-03       Impact factor: 17.745

Review 5.  Cellular Receptors Involved in KSHV Infection.

Authors:  Emma van der Meulen; Meg Anderton; Melissa J Blumenthal; Georgia Schäfer
Journal:  Viruses       Date:  2021-01-17       Impact factor: 5.048

Review 6.  The ORF45 Protein of Kaposi's Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle.

Authors:  Natalie Atyeo; Bernadett Papp
Journal:  Viruses       Date:  2022-09-11       Impact factor: 5.818

7.  Compartmented neuronal cultures reveal two distinct mechanisms for alpha herpesvirus escape from genome silencing.

Authors:  Orkide O Koyuncu; Margaret A MacGibeny; Ian B Hogue; Lynn W Enquist
Journal:  PLoS Pathog       Date:  2017-10-26       Impact factor: 6.823

8.  The Kaposi's Sarcoma-Associated Herpesvirus Protein ORF42 Is Required for Efficient Virion Production and Expression of Viral Proteins.

Authors:  Matthew Butnaru; Marta Maria Gaglia
Journal:  Viruses       Date:  2019-08-02       Impact factor: 5.048

Review 9.  Towards Understanding KSHV Fusion and Entry.

Authors:  Stephen J Dollery
Journal:  Viruses       Date:  2019-11-18       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.